1. Becasen JS, Denard CL, Mullins MM, Higa DH, Sipe TA. Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006–2017. Am J Public Health. 2019;109(1):e1–8.
2. Centers for Disease Control and Prevention. Core indicators for monitoring the Ending the HIV Epidemic initiative : HIV diagnoses and linkage to HIV medical care, 2019 and 2020 (preliminary data reported through June 2020). HIV Surveillance Data Tables 2020;1(No. 6) http://www.cdc.gov/hiv/library/reports/surveillance-data-tables/vol-1-no-6/index.html. Published October 2020. Accessed [November 2020].
3. Prevention. CfDCa. Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2014–2018. 2020 [Available from: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. November 2020
4. Baral SD, Poteat T, Stromdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–22.
5. Poteat T, Reisner SL, Radix A. HIV epidemics among transgender women. Curr Opin HIV AIDS. 2014;9(2):168–73.